Informação da revista
Vol. 36. Núm. S1.
Páginas 3-5 (Novembro 2017)
Partilhar
Partilhar
Baixar PDF
Mais opções do artigo
Vol. 36. Núm. S1.
Páginas 3-5 (Novembro 2017)
Introduction
Open Access
Commemorating twenty years since the first catheter‐based pulmonary vein isolation to treat atrial fibrillation by ablation
Visitas
3903
Pedro Adragão
Serviço de Cardiologia, CHLC, Hospital de Santa Cruz, Carnaxide, Portugal
Este item recebeu

Under a Creative Commons license
Informação do artigo
Texto Completo
Bibliografia
Baixar PDF
Estatísticas
Material adicional (1)
Texto Completo

Surgical pulmonary vein isolation by ablation as a treatment for atrial fibrillation was first performed in isolation in 1996 at Hospital de Santa Cruz in Portugal, as a complementary therapy to mitral valve surgery in patients with rheumatic mitral valve disease, in order to reduce the morbidity associated with maze surgery.1

This innovative surgical approach, performed by Queiroz e Melo, replaced the maze technique's fragmentation of the atria using surgical incisions by application of radiofrequency energy along the pulmonary veins.2 Its efficacy was assessed by electrophysiological studies that showed bilateral pulmonary vein isolation3 and it reduced postoperative morbidity.

The surgical procedure reproduced a preliminary study in sheep by Fieguth et al., which showed that atrial fibrillation was not inducible following surgical isolation of the pulmonary veins.4

In 1996, having confirmed the efficacy of surgical isolation and the feasibility of reproducing the same effect via catheter, we performed the first percutaneous procedure, in a patient with mitral stenosis and atrial fibrillation, at Hospital de Santa Cruz (Appendix A. Supplementary data). This patient was indicated for balloon mitral valvuloplasty due to rheumatic mitral valve stenosis, and after valve dilatation, using the same transseptal route, we isolated the pulmonary veins.

We then performed the same procedure in four more patients and presented the initial results at the 18th Portuguese Congress of Cardiology in April 19975 (Appendix A. Supplementary data) and in the Feature Session of the 18th Annual Scientific Sessions of the North American Society of Pacing and Electrophysiology in May of the same year.6 (Appendix A. Supplementary data).

After five years of follow‐up, two of the patients were in sinus rhythm, two in atrial fibrillation and one underwent ablation for atrial flutter four years after the first ablation. In the latter patient, the effectiveness of the previous isolation in eliminating solutions of continuity was demonstrated by three‐dimensional mapping (CARTO and EnSite).7

After Pierre Jaïs had reported that episodes of atrial fibrillation had a focal origin and showed that these foci could be ablated, in 1998 Michel Haïssaguerre confirmed the importance of foci in the pulmonary veins.8,9

However, application of radiofrequency to foci in the pulmonary veins, as advocated by Haïssaguerre, was not without risk, and was accompanied by an unacceptably high incidence of pulmonary vein stenosis.10 In 2000, it was confirmed that the only solution was to return to the strategy that we initially proposed, that of electrical isolation of the pulmonary veins,11 and the 2012 HRS/EHRA/ECAS consensus statement on ablation of atrial fibrillation identified pulmonary vein isolation as the cornerstone for ablation treatment of atrial fibrillation.12

It was demonstrated that the particular characteristics of the pulmonary vein ostia, including their short refractory periods and close relationship with the autonomic nervous system,13–15 explained their importance in the genesis and maintenance of atrial fibrillation.16

In view of the pandemic proportions of atrial fibrillation (2.5% of the population aged over 40 in Portugal),17 the scene was set for this new treatment modality to be rolled out in the main centers for cardiac electrophysiology. At the same time, rapid advances in technology led to the development of three‐dimensional mapping and ablation systems such as CARTO,18 EnSite19 and NavX,20 which provided anatomical precision and enabled the safe creation of contiguous and spatially controlled lesions.

The work of Carlo Pappone21 in three‐dimensional mapping and the precise location of ablation lesions has played a major role in the development of modern electrophysiology; he has also been a pioneer of robotic systems.22 However, as has happened with other important scientific breakthroughs, the electrophysiological community was unprepared to fully embrace the new technology.

Pulmonary vein isolation was shown to be ideal for patients with relatively undilated left atria, but was less effective in cases of atria that are enlarged or severely fibrosed.23–25 Success rates in paroxysmal forms reach 70% but are considerably lower in persistent and long‐standing persistent forms.26

There have accordingly been attempts to find alternative therapies, including radiofrequency application to complex fractionated atrial electrograms (CFAE)27 and associating linear lesions in order to create an ‘electrophysiological maze’ effect.28 Besides the pulmonary vein antrum, other areas have been the focus of attention, particularly the superior vena cava29 and the atrial appendage.30

However, the apparent effectiveness of such interventions, which were intended to complement pulmonary vein isolation, was not confirmed by the randomized STAR AF II trial,31 which compared pulmonary vein isolation alone, pulmonary vein isolation plus ablation of CFAEs, and pulmonary vein isolation plus additional linear ablation.

In acknowledgment of this result, the 2016 European Society of Cardiology guidelines for the management of atrial fibrillation26 confirm pulmonary vein isolation as the treatment of choice for atrial fibrillation, even in persistent forms, and state that routine deployment of additional linear lesions or ablation of CFAEs has no additional benefit in the first procedure. The guidelines also indicate that single‐application ablation techniques such as cryoablation have similar outcomes to point‐by‐point isolation, citing the results of the FIRE AND ICE trial.32

However, although pulmonary vein isolation alone appears to be accepted as the treatment of choice, long‐term results indicate a success rate of only 50% in persistent atrial fibrillation. This figure is obviously unsatisfactory.

Pulmonary vein isolation for atrial fibrillation ablation is generally a safe procedure, with low morbidity and mortality (0.1%),33 but it does have potential complications that must be prevented or controlled, such as phrenic nerve injury or atrioesophageal fistula.34–37

The quest for a definitive treatment of atrial fibrillation requires a kind of intellectual restlessness, constantly searching for new forms of dynamic mapping, such as four‐dimensional imaging,38 new ways to analyze electrograms (rotors and stable CFAEs),39,40 new methods for applying energy to reduce reconduction,41,42 and new therapeutic targets.43–45

No stone should be left unturned. We need new research paths to develop complementary or alternative therapies to pulmonary vein electrical isolation for the treatment of atrial fibrillation.

In this symposium, as we commemorate 20 years since the first pulmonary vein isolation, the main actors in the field will present and discuss new perspectives and strategies to understand and treat the fascinating puzzle that is atrial fibrillation.

Conflicts of interest

The author has no conflicts of interest to declare.

Appendix A
Supplementary data

The following are the supplementary data to this article:

References
[1]
J.Q. Melo, J. Neves, P. Adragão, et al.
When and how to report results of surgery on atrial fibrillation.
Eur J Cardiothorac Surg, 12 (1997), pp. 739-744
discussion 744‐5
[2]
J.Q. Queiróz e Melo, P. Adragão, J. Neves, et al.
Atrial fibrillation surgery using intraoperative radiofrequency.
Rev Port Cardiol, 17 (1998), pp. 377-379
[3]
P. Adragão, J. Melo, C. Aguiar, et al.
Evaluation of bilateral pulmonary vein isolation for the treatment of atrial fibrillation: value of postoperative electrophysiological study.
Rev Port Cardiol, 21 (2002), pp. 1281-1293
[4]
H.G. Fieguth, T. Wahlers, H.G. Borst.
Inhibition of atrial fibrillation by pulmonary vein isolation and auricular resection‐experimental study in a sheep model.
Eur J Cardiothorac Surg, 11 (1997), pp. 714-721
[5]
P. Adragão, F. Machado, L. Parreira, et al.
Ablação por cateter de fibrilhação auricular com valvulotomia mitral de balão simultânea: novo método ‐ experiência inicial.
Rev Port Cardiol, 16 (1997),
I‐1
[6]
P. Adragão, F. Machado, L. Parreira, et al.
Radiofrequency ablation of atrial fibrillation and simultaneous mitral valvuloplasty by percutaneous approach: a new method – first experience.
Pacing Clin Electrophysiol, 20 (1997), pp. 112
[7]
P. Adragão, F.P. Machado, C. Aguiar, et al.
Ablation of atrial fibrillation in mitral valve disease patients: five year follow‐up after percutaneous pulmonary vein isolation and mitral balloon valvuloplasty.
Rev Port Cardiol, 22 (2003), pp. 1025-1036
[8]
M. Haissaguerre, P. Jais, D.C. Shah, et al.
Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins.
N Engl J Med, 339 (1998), pp. 659-666
[9]
P. Jaïs, M. Haïssaguerre, D.C. Shah, et al.
A focal source of atrial fibrillation treated by discrete radiofrequency ablation.
Circulation, 95 (1997), pp. 572-576
[10]
I.M. Robbins, E.V. Colvin, T.P. Doyle, et al.
Pulmonary vein stenosis after catheter ablation of atrial fibrillation.
Circulation, 98 (1998), pp. 1769-1775
[11]
M. Haïssaguerre, D.C. Shah, P. Jaïs, et al.
Electrophysiological breakthroughs from the left atrium to the pulmonary veins.
Circulation, 102 (2000), pp. 2463-2465
[12]
H. Calkins, K.H. Kuck, R. Cappato, et al.
2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow‐up, definitions, endpoints, and research trial design.
Europace, 14 (2012), pp. 528-606
[13]
P. Adragão, K.R. Santos, C. Aguiar, et al.
Atrial fibrillation and effective refractory period of the pulmonary vein ostia.
Rev Port Cardiol, 21 (2002), pp. 1125-1134
[14]
C. Pappone, V. Santinelli, F. Manguso, et al.
Pulmonary vein denervation enhances long‐term benefit after circumferential ablation for paroxysmal atrial fibrillation.
Circulation, 109 (2004), pp. 327-334
[15]
H.Y.K. Nakagawa, B.J. Scherlag, V. Katari, et al.
Ablation of autonomic ganglia.
A practical approach to catheter ablation of atrial fibrillation, 1st ed., pp. 218-230
[16]
P. Adragão, C. Aguiar, F. Morgado, et al.
Value of isolating the pulmonary veins in the treatment of atrial fibrillation Sinus rhythm recovery after pulmonary vein isolation and persistent fibrillation inside the disconnected pulmonary veins.
Rev Port Cardiol, 21 (2002), pp. 221-227
[17]
D. Bonhorst, M. Mendes, P. Adragão, et al.
Prevalence of atrial fibrillation in the Portuguese population aged 40 and over: the FAMA study.
Rev Port Cardiol, 29 (2010), pp. 331-350
[18]
D. Schwartzman, K.H. Kuck.
Anatomy‐guided linear atrial lesions for radiofrequency catheter ablation of atrial fibrillation.
Pacing Clin Electrophysiol, 21 (1998), pp. 1959-1978
[19]
P. Adragão, D. Cavaco, C. Aguiar, et al.
Identification of pulmonary vein foci by non‐contact mapping in patients with paroxysmal atrial fibrillation.
Rev Port Cardiol, 22 (2003), pp. 475-486
[20]
P.G. Novak, L. Macle, B. Thibault, et al.
Enhanced left atrial mapping using digitally synchronized NavX three‐dimensional nonfluoroscopic mapping and high‐resolution computed tomographic imaging for catheter ablation of atrial fibrillation.
Heart Rhythm, 1 (2004), pp. 521-522
[21]
C. Pappone, S. Rosanio, G. Oreto, et al.
Circumferential radiofrequency ablation of pulmonary vein ostia: a new anatomic approach for curing atrial fibrillation.
Circulation, 102 (2000), pp. 2619-2628
[22]
C. Pappone, G. Vicedomini, F. Manguso, et al.
Robotic magnetic navigation for atrial fibrillation ablation.
J Am Coll Cardiol, 47 (2006), pp. 1390-1400
[23]
J. Abecasis, R. Dourado, A. Ferreira, et al.
Left atrial volume calculated by multi‐detector computed tomography may predict successful pulmonary vein isolation in catheter ablation of atrial fibrillation.
Europace, 11 (2009), pp. 1289-1294
[24]
F.M. Costa, A.M. Ferreira, S. Oliveira, et al.
Left atrial volume is more important than the type of atrial fibrillation in predicting the long‐term success of catheter ablation.
Int J Cardiol, 184 (2015), pp. 56-61
[25]
G.R. Vergara, N.F. Marrouche.
Tailored management of atrial fibrillation using a LGE‐MRI based model: from the clinic to the electrophysiology laboratory.
J Cardiovasc Electrophysiol, 22 (2011), pp. 481-487
[26]
P. Kirchhof, S. Benussi, D. Kotecha, et al.
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS.
Eur Heart J, 37 (2016), pp. 2893-2962
[27]
K. Nademanee, J. McKenzie, E. Kosar, et al.
A new approach for catheter ablation of atrial fibrillation: mapping of the electrophysiologic substrate.
J Am Coll Cardiol, 43 (2004), pp. 2044-2053
[28]
M.D. O’Neill, P. Jaïs, Y. Takahashi, et al.
The stepwise ablation approach for chronic atrial fibrillation‐evidence for a cumulative effect.
J Interv Card Electrophysiol, 16 (2006), pp. 153-167
[29]
A. Corrado, A. Bonso, M. Madalosso, et al.
Impact of systematic isolation of superior vena cava in addition to pulmonary vein antrum isolation on the outcome of paroxysmal, persistent, and permanent atrial fibrillation ablation: results from a randomized study.
J Cardiovasc Electrophysiol, 21 (2010), pp. 1-5
[30]
L. Di Biase, J.D. Burkhardt, P. Mohanty, et al.
Left atrial appendage: an underrecognized trigger site of atrial fibrillation.
Circulation, 122 (2010), pp. 109-118
[31]
A. Verma, C.Y. Jiang, T.R. Betts, et al.
STAR AF II Investigators Approaches to catheter ablation for persistent atrial fibrillation.
N Engl J Med, 372 (2015), pp. 1812-1822
[32]
K.H. Kuck, J. Brugada, A. Fürnkranz, et al.
FIRE AND ICE investigators Cryoballoon or radiofrequency ablation for paroxysmal atrial fibrillation.
N Engl J Med, 374 (2016), pp. 2235-2245
[33]
R. Cappato, H. Calkins, S.A. Chen, et al.
Updated worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation.
Circ Arrhythm Electrophysiol, 3 (2010), pp. 32-38
[34]
F. Sacher, K.H. Monahan, S.P. Thomas, et al.
Phrenic nerve injury after atrial fibrillation catheter ablation: characterization and outcome in a multicenter study.
J Am Coll Cardiol, 47 (2006), pp. 2498-2503
[35]
C. Pappone, H. Oral, V. Santinelli, et al.
Atrio‐esophageal fistula as a complication of percutaneous transcatheter ablation of atrial fibrillation.
Circulation, 109 (2004), pp. 2724-2726
[36]
M.I. Scanavacca, A. D’ávila, J. Parga, et al.
Left atrial‐esophageal fistula following radiofrequency catheter ablation of atrial fibrillation.
J Cardiovasc Electrophysiol, 15 (2004), pp. 960-962
[37]
J.T. Medeiros De Vasconcelos, S.D. Filho, J. Atié, et al.
Atrial‐oesophageal fistula following percutaneous radiofrequency catheter ablation of atrial fibrillation: the risk still persists.
Europace, 19 (2017), pp. 250-258
[38]
P. Adragão, P. Carmo, D. Cavaco, et al.
Ablation of stable complex fractionated atrial electrogram defined by dynamic overlaid mapping in persistent atrial fibrillation.
Rev Port Cardiol, (2017),
pii:S0870‐2551(17)30156‐7
[39]
S.M. Narayan, D.E. Krummen, K. Shivkumar, et al.
Treatment of atrial fibrillation by the ablation of localized sources: CONFIRM (Conventional Ablation for Atrial Fibrillation With or Without Focal Impulse and Rotor Modulation) trial.
J Am Coll Cardiol, 60 (2012), pp. 628-636
[40]
P. Adragão, P. Carmo, D. Cavaco, et al.
Relationship between rotors and complex fractionated electrograms in atrial fibrillation using a novel computational analysis.
Rev Port Cardiol, (2017), pp. 30157-30159
pii:S0870‐2551(17)
[41]
K. Yokoyama, H. Nakagawa, D.C. Shah, et al.
Novel contact force sensor incorporated in irrigated radiofrequency ablation catheter predicts lesion size and incidence of steam pop and thrombus.
Circ Arrhythm Electrophysiol, 1 (2008), pp. 354-362
[42]
S. Boveda, R. Providência, J.P. Albenque, et al.
Real‐time assessment of pulmonary vein disconnection during cryoablation of atrial fibrillation: can it be ‘achieved’ in almost all cases?.
Europace, 16 (2014), pp. 826-833
[43]
H. Kottkamp, J. Berg, R. Bender, et al.
Box isolation of fibrotic areas (BIFA): a patient‐tailored substrate modification approach for ablation of atrial fibrillation.
J Cardiovasc Electrophysiol, 27 (2016), pp. 22-30
[44]
Y. Takahashi, S. Iwai, S. Yamashita, et al.
Novel mapping technique for localization of focal and reentrant activation during atrial fibrillation.
J Cardiovasc Electrophysiol, (2017),
PMID: 28063269 [Epub ahead of print]
[45]
J. Seitz, C. Bars, G. Théodore, et al.
AF ablation guided by spatiotemporal electrogram dispersion without pulmonary vein isolation: a wholly patient‐tailored approach.
J Am Coll Cardiol, 69 (2017), pp. 303-321
Copyright © 2017. Sociedade Portuguesa de Cardiologia
Idiomas
Revista Portuguesa de Cardiologia
Opções de artigo
Ferramentas
Material Suplementar
en pt

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos

Ao assinalar que é «Profissional de Saúde», declara conhecer e aceitar que a responsável pelo tratamento dos dados pessoais dos utilizadores da página de internet da Revista Portuguesa de Cardiologia (RPC), é esta entidade, com sede no Campo Grande, n.º 28, 13.º, 1700-093 Lisboa, com os telefones 217 970 685 e 217 817 630, fax 217 931 095 e com o endereço de correio eletrónico revista@spc.pt. Declaro para todos os fins, que assumo inteira responsabilidade pela veracidade e exatidão da afirmação aqui fornecida.